Figure 7 | Scientific Reports

Figure 7

From: Kefir peptides alleviate particulate matter <4 μm (PM4.0)-induced pulmonary inflammation by inhibiting the NF-κB pathway using luciferase transgenic mice

Figure 7

Hypothetical scheme of the kefir peptides regulatory pathway. The effects of kefir peptides on the anti-inflammatory response are hypothesized to occur through the NF-κB signaling pathway. The diagram shows that kefir peptides might inhibit the expression of p-NF-κB, NLRP3, caspase-1, IL-1β, IL-6, TNF-α, α-SMA, and IL-4. Kefir peptides might also increase the SOD activity to reduce the ROS generation.

Back to article page